LexaGene Holdings Inc.
LXXGF · OTC
2/28/2022 | 2/28/2021 | 2/29/2020 | 2/28/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 29.6% | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -621.4% | -173.8% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13,348.1% | -15,991.4% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -14,101% | -17,145.8% | – | – |
| EPS Diluted | -0.09 | -0.096 | -0.1 | -0.13 |
| % Growth | 6.4% | 3.3% | 23.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |